Cargando…
An expanded biomarker panel for the detection of prostate cancer from urine DNA
BACKGROUND: Prostate cancer diagnosis using the PSA test remains controversial because of overdiagnosis and overtreatment of potentially indolent cancers. There remains a need to increase the diagnostic lead time and to target treatment to patients with significant disease. One possible approach to...
Autores principales: | Brikun, Igor, Nusskern, Deborah, Freije, Diha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598372/ https://www.ncbi.nlm.nih.gov/pubmed/31297302 http://dx.doi.org/10.1186/s40164-019-0137-x |
Ejemplares similares
-
A panel of DNA methylation markers for the detection of prostate cancer from FV and DRE urine DNA
por: Brikun, Igor, et al.
Publicado: (2018) -
A panel of DNA methylation markers reveals extensive methylation in histologically benign prostate biopsy cores from cancer patients
por: Brikun, Igor, et al.
Publicado: (2014) -
Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer
por: Nilsson, J, et al.
Publicado: (2009) -
Improved urine DNA methylation panel for early bladder cancer detection
por: Fang, Qixun, et al.
Publicado: (2022) -
Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine
por: Lima, Ana Rita, et al.
Publicado: (2019)